Author(s): Mukesh Chandra Sharma, Mukul Sharma

Email(s): mukulscsharma@gmail.com , mukul.sharma@medicaps.ac.in

DOI: 10.52711/0974-360X.2023.00418   

Address: Mukesh Chandra Sharma1, Mukul Sharma1,2*
1School of Pharmacy, Devi Ahilaya Vishwavidyalaya, Indore (M.P.)
2Faculty of Pharmacy, Medi-Caps University, Indore (M.P.)
*Corresponding Author

Published In:   Volume - 16,      Issue - 5,     Year - 2023


ABSTRACT:
Plasma is the fourth state of matter other than solid, liquid and gases. About 99 percent of mixture of free positive negative charges, neutral particles and photons. The plasma exists in two forms: hot plasma and cold plasma. Hot plasma is used in metallurgical operations while cold plasma is used in medical, skin psoriasis treatment, food agricultural, preservation and waste water treatment. Many clinical studies prove the effectiveness of cold plasma in dermatological disease management. Recent researches have established that combined use of cold plasma and nano-formulations is helpful in delivery of poorly water-soluble drugs. Plaque psoriasis is an autoimmune disorder in which silvery, thick, dead layer of skin shades off and cause inflammation, sometimes bleeding. It occurs in 3-4 percent of total world population. Scientific studies have proved that nano-scale particles permeate easily and interact with immune cells like lnterleukin-16, cytokines and TNF-alfa during inflammation and autoimmune disorders. As a result of which, thick layer of keratinocytes is produced and formation of TNF-alfa and interleukin is inhibited which are the causes of Plaque psoriasis. Since conventional medication has only been helpful in managing it, researches have been carried out using various techniques like phototherapy, use of UVA, UVB, IPL (Intense Pulsed Light), PDL (Pulsed Dye Light), LASER and low-level LASER light etc. but their excess exposure causes risk of skin cancer. Other therapies like use of nanometric Liposomes, Niosomes and their combination therapy are some novel clinical techniques for combating symptoms but are still in clinical trial. Since, Plasma therapy is non irritating and stops the triggering mechanism of inflammation, hence the use of nanotechnological topical formulation in combination with plasma therapy has the potential to become possible treatment of Plaque Psoriasis in future.


Cite this article:
Mukesh Chandra Sharma, Mukul Sharma. Novel applications of Cold Atmospheric Plasma for the treatment of Plaque Psoriasis. Research Journal of Pharmacy and Technology 2023; 16(5):2543-8. doi: 10.52711/0974-360X.2023.00418

Cite(Electronic):
Mukesh Chandra Sharma, Mukul Sharma. Novel applications of Cold Atmospheric Plasma for the treatment of Plaque Psoriasis. Research Journal of Pharmacy and Technology 2023; 16(5):2543-8. doi: 10.52711/0974-360X.2023.00418   Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-5-77


REFERENCES:
1.    Lee YS. Lee MH. Kim HJ.  Won HR. Kim CH. Non-thermal atmospheric plasma ameliorates imiquimod-induced psoriasis-like skin inflammation in mice through inhibition of immune responses and up-regulation of PD-L1 expression. 2017.14;7(1):15564. doi: 10.1038/s41598-017-15725-7
2.    Zhang P. Wu MX. A clinical review of phototherapy for psoriasis. Lasers Med Sci. 2018;33(1):173-180. doi: 10.1007/s10103-017-2360-1.
3.    Anderson TF. Waldinger TP. Voorhees. UVB phototherapy an overview. J. J. Arch Dermatol.  1984;120(11):1502-7.
4.    Chen Z et al. Cold atmospheric plasma discharged in water and its potential use in cancer therapy. 2016:1-18. doi.10.1088/1361-6463/50/1/015208.
5.    Tokura Y. Mori T. Hino R. Psoriasis and other Th17-mediated skin diseases. Journal of UOEA. 2010; 1;32(4):317-28. doi: 10.7888/juoeh.32.317.
6.    Xie J. Huang S. Huang H. Deng X. Yue P. Lin J. Yang M. Han L. Zhang DK. Advances in the Application of Natural Products and the Novel Drug Delivery Systems for Psoriasis. Front Pharmacol. 2021; 21(12):644952. doi: 10.3389/fphar.2021.644952.
7.    Dhalendra G. Satapathy T. Roy A. Animal Models for Inflammation: A Review. Asian J. Pharm. Res. 2013; 3(4):207-212.
8.    Kulkarni RR. Phadtare DG, Saudagar RB. A Novel Approach Towards Nanosuspension. Asian J. Pharm. Res. 2015; 5(4):186-194.
9.    Keidar M.  Guron C. Trink B. System and methods of cold plasma therapy. 2014.WO 2013/040473 Al.
10.    Watson G, Magnolia A, Sanford, Cave C, Jacofsky, Marc CN, Central A, Phoenix J, Devid J, Williams Rd, Peoria. Cold plasma associated methods and devices. 2013.WO 2013/040473 Al.
11.    Wirtz MZ. Cold atmospheric plasma treatment of actinic keratosis and non- melanoma skin cancer. 2018.WO 2018/069549.
12.    Rendon A. Schakel K. Psoriasis pathogenesis and treatment. International journal of molecular sciences.2019;20(6):1475.
13.    Indalkar YR. Pimpodkar NV. Godase AS. Gaikwad PS. A Compressive Review on the Study of Nanotechnology for Herbal Drugs. Asian J. Pharm. Res. 2015; 5(4):203-207. doi: 10.5958/2231-5691.2015.00031.3
14.    Peter FC. et al. Successful treatment of actinic keratoses using nonthermal atmospheric pressure plasma: A case series. J. American Aca. Derma. Mosby. Inc. Us. 2017;76(2):349-350. doi.10.1016/J.JAAD.2016.09.004
15.    Sharma M. Dubey S. Darwhekar GN. Jain S.K. Diverse applications of Plasma. American Ins Phy. Conference Proceedings 1670. 030027 2015. doi: 10.1063/1.4926711.
16.    Al Robaee AA. Alzolibani AA. Narrowband ultraviolet B phototherapy improves the quality of life in patients with psoriasis. Saudi medical journal. 2011; 1;32(6):603-6.
17.    Nayak N. Somanna P. Patil AB. Radhakrishnan A. Progress in novel ultra-deformable vesicular drug carrier in the topical and transdermal treatment of psoriasis. Ther. Deliv. 2020;11(12):807-819. doi: 10.4155/tde-2020-0081.
18.    Sun L. Liu Z. Cun D. Tong HH. Zheng Y. Application of nano- and micro-particles on the topical therapy of skin-related immune disorders. Curr. Pharm. Des. 2015;21(19):2643-67. doi: 10.2174/1381612821666150416100516.
19.    https://phys. org/news/2018-0 5-dc-voltage-cold
20.    Vincent N. Ramya DD. Vedha HB. Progress in Psoriasis Therapy via Novel Drug Delivery Systems Dermatol Reports.2014;8;6(1):5451. doi: 10.4081/dr.2014.5451.
21.    Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: a systematic review. Sleep medicine reviews. 2016, 29:63-75.
22.    Singh N. Sondhi S. Jindal S. Pandit V. Ashawat MS. Treatment and Management for patients with mild to severe Psoriasis: A Review. Asian J. Pharm. Res. 2020; 10(4):286-292.
23.    Arora P. Sarkar RK. Garg VK. Arya L. Lasers for Treatment of Melasma and Post-Inflammatory Hyperpigmentation. J. Cutan. Aesthet. Surg. 2012; 5(2): 93–103.
24.    Khan MY. Gupta P. Bihari B. Sharma VK. Aziz I. A Review- Miracle of Nanotechnology in Cosmetics. Asian J. Pharm. Res. 2014; 4(1):16-23.
25.    Goldberg DJ. Current trends in intense pulsed light. The J. Clin. Aes. Derma. 2012; 5(6):45–53.
26.    Tokura Y. Mori T. Hino R. Psoriasis and other Th17-mediated skin diseases. J. UOEA. 2010; 1;32(4):317-28. doi: 10.7888/juoeh.32.317.
27.    Nakamura M. Farahnik B. Bhutani T. Recent advances in phototherapy for psoriasis. F1000 Res. 2016;(13)5:1684. doi: 10.12688/f1000research.8846.1.
28.    Berneburg M. Brod C. Benedix F.  Rocken M. New and established indications for phototherapy with narrowband UVB. J. Dtsch. Dermatol Ges. 2005;3(11):874-82.  doi: 10.1111/j.1610-0387.2005.05072.x.
29.    Ali G. Elsayed AK. Nandakumar M. Bashir M. Younis I. Abu AY. Memon B. Temanni R. Abubaker F. Taheri S. Abdelalim EM. Keratinocytes derived from patient-specific induced pluripotent stem cells recapitulate the genetic signature of psoriasis disease. Stem cells and development. 2020;1;29(7):383-400.
30.    Breit R. UV in der Dermatologie: Spektren--Gerate--Moglichkeiten [Ultraviolet in dermatology: spectra--instruments--possibilities]. Hautarzt. 1985;36(9):496-503. German. PMID: 4066321.
31.    Gijbels MJ. Elliott GR. HogenEsch H. Zurcher C. Van Den Hoven A. Bruijnzeel PL. Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm). Experimental dermatology. 2000 Oct;9(5):351-8.
32.    Gregory A. Watson. Robert M. Hummel. Marc C. Jacofsky. David J. Jacofsky. Cold plasma treatment devices and associated methods. 2016.US9384947B2.
33.    Foerster V. Murtagh J. Fiander M. Pulsed dye laser therapy of port wine stains. Technology Report 78. Ottawa. On: canadian agency for drugs and technologies in health (CADTH).2007. https://database.inahta.org/article/6595#.YsiCAzjyrpo.link
34.    Abdullah AN. Keczkes K. Cutaneous and ocular side-effects of PUVA photochemotherapy--a 10-year follow-up study. Cli. Exp. Derma. 1989;1;14(6):421-4.
35.    Al‐Hamamy HR. Al‐Mashhadani SA. Mustafa IN. Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of Plaque‐type psoriasis. Int. J. Derma. 2014;53(12):1531-5.
36.    Chakravorty R. Nanosuspension as an emerging Nanotechnology and Techniques for its Development. Res. Journal of Pharmacy and Technology. 2022; 15(1):489-3.
37.    Krishnan PRR. Sivakumar R. Nanotechnology: Modern Formulation and Evaluation Techniques - An Overview. Research J. Pharm. and Tech 2019; 12(8): 4039-4044.doi:10.5958/0974360X.2019.00696.6
38.    Yadav K. Singh D. Singh MR. Development and Characterization of Corticosteroid loaded Lipid carrier system for Psoriasis. Res. J. Pharm. Tech. 2021; 14(2):966-970.
39.    Szymański Ł. Skopek R. Palusińska M. Schenk T. Stengel S. Lewicki S. Kraj L. Kamiński P. Zelent A. Retinoic acid and its derivatives in skin cells. 2020;11;9(12):2660. doi: 10.3390/cells9122660.
40.    Xie XJ. Di TT. Wang  Y. Wang MX.  Meng YJ.  Lin Y. Xu XL. Li P.  Zhao JX. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Mol. Imm. 2018;101:386-395. doi: 10.1016/j. molimm. 2018.07.011.
41.    Tiwari S. Singh S. Tripathi PK. Dubey CK. A Review- Nanogel Drug Delivery System. Asian J. Res. Pharm. Sci. 2015; 5(4): 253-255.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available